维普中文期刊产品整合服务
229篇 您的检索式:作者名="Chakravarty P"
    题名 作者 年代 出处 被引量
1RTOG 0211:a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients显示文摘PURPOSE: To determine the safety and efficacy of gefitinib,an epidermal growth factor receptor(EGFR) tyrosine kinase inhibitor,in combination with radiation for newly diagnosed glioblastoma(GBM) patients.METHODS AND MATERIALS: Between March 21,2002,and May 3,2004,Radiation Therapy Oncology Group(RTOG) 0211 enrolled 31 and 147GBM patients in the phase 1 and 2 arms,respectively.Treatment consisted of daily oral gefinitnib started at the time of conventional cranial radiation therapy(RT) and continued post RT for 18 months or until progression.Tissue microarrays from 68 cases were analyzed for EGFR expression.RESULTS: The maximum tolerated dose(MTD) of gefitinib was determined to be 500 mg in patients on non-enzyme-inducing anticonvulsant drugs(non-EIAEDs).All patients in the phase 2 component were treated at a gefitinib dose of 500 mg;patients receiving EIADSs could be escalated to 750 mg.The most common side effects of gefitinib in combination with radiation were dermatologic and gastrointestinal.Median survival was 11.5 months for patients treated per protocol.There was no overall survival benefit for patients treated with gefitinib + RT when compared with a historical cohort of patients treated with RT alone,matched by RTOG recursive partitioning analysis(RPA) class distribution.Younger age was significantly associated with better outcome.Per protocol stratification,EGFR expression was not found to be of prognostic value for gefitinib + RT-treated patients.CONCLUSIONS: The addition of gefitinib to RT is well tolerated.Median survival of RTOG 0211 patients treated with RT with concurrent and adjuvant gefitinib was similar to that in a historical control cohort treated with radiation alone.Chakravarti A Wang M Robins HI Lautenschlaeger T Curran WJ Brachman DG Schultz CJ Choucair A Dolled-Filhart M Christiansen J Gustavson M Molinaro A Mischel P Dicker AP Bredel M Mehta M 2013中国神经肿瘤杂志2013,11,1:8
2DNA polymorphism haplotypes of the human apolipoprotein APOA1 - APOC3-APOA4 gene cluster显示文摘Antonarakis SE Oettgen P Chakravarti A 1988Hum Genet1988,80,3:1
3Oral hydrogesterone versus in travaginal micronised progesterone as luteal phase support in assisted reproductive technology(ART) cycles:Results of a randomised study显示文摘Chakravarty B N Shirazee H H Dam P 2005J Steroid Biochem Mol Biol2005,97,5:1
4Analysis of nonlinear blood flow in a stenosed flexible artery显示文摘Chakravarty S Datta A Mandal P K 1995Int J Engng Sci1995,33,12:1
5Parti- tioned presentation of multicomponent bundle prices: evalua- tion, choice and underlying processing effects显示文摘Chakravarti D Krish R Paul P et A1 2002Journal of Consumer Psychology2002,12,3:1
6Differential influence of ectomycorrhizae on plant growth and disease resistance in Pinus sylvestris seedlings显示文摘Chakravarty P Unestam T 1987Journal of Phytopathology1987,120,2:1
7A nonlinear tow-Dimensional model of blood flow in an overlapping arterial stenosis subjected to body acceleration显示文摘Chakravarty S Mandal P K 1996Math Comput Modelling1996,24,1:1
8Forest Depend ence and Income Distribution in a Subsistence Economy Evidence from India显示文摘REDDY S R C CHAKRAVARTY S P 1999World development1999,45,:1
9J Med Chem显示文摘Chakravarty P K Carlp L Weber M J 198326:6331983,26,:1
10Zinc in human maligancies显示文摘Chakravarty P K Ghosh A Chowdhury J R et al 1986Neoplasma1986,33,1:1
11Integrated control of Fusarium damping-off in conifer seedlings显示文摘Chakravarty P Khasa D Dancik B 1999Journal of Plant Disease and Protection1999,106,4:1
12Interleukin-6 as a therapeutic target in human ovarian cancer 显示文摘Coward J Kulbe H Chakravarty P 2011Clin Cancer Res2011,17,:1
13Rabbit arterial thromobosis production by systemic procedures显示文摘Constantinides P Chakravarti RN 1961Arch Pathol1961,72,8:1
14Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology(ART)cycles:results of a randomized study显示文摘Chakravarty BN Shirazee HH Dam P 2005J Steroid Biochem Mol Biol2005,97,:1
15Development of human protein reference database as an initial platform for approaching systems biology in humans 显示文摘PERI S NAVARRO J D AMANCHY R KRISTIANSEN T Z JONNALAGADDA C K SURENDRANATH V NIRAN JAN V MUTHUSAMY B GANDHI T K GRONBORG M IBARROLA N DESHPANDE N SHANKER K SHIVASHANKAR H N RASHMI B P RAMYA M A ZHAO Z CHANDRIKA K N PADMA N HARSHA H C YATISH A J KAVITHA M P MENEZES M CHOUDHURY D R SURESH S GHOSH N SARAVANA R CHANDRAN S KRISHNA S JoY M ANAND S K MADAVAN V JOSEPH A WONG G W SCHIEMANN W P CONSTANTINESCU S N HUANG L KHOSRAVI-FAR R STEEN H TEWARI M GHAFFARI S BLOBE G C DANG C V GARCIA J G PEVSNER J JENSEN O N ROEPSTORFF P DESHPANDE K S CHINNAIYAN A M HAMOSH A CHAKRAVARTI A PANDEY A 2003Genome Research2003,13,10:1
16Prolactin and heregulin override DNA damage-induced growth arrest and promote phosphatidylinositol-3 kinase-dependent proliferation in breast cancer cells 显示文摘Chakravarti P Henry M K Quelle F W 2005Int J Oncol2005,26,2:1
17Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation显示文摘Fan Z Chakravarty P Alfieri A 2000Cancer Gene Ther2000,7,10:1
18Synthesis,crystal structures and properties of temary copper (Ⅱ) complexes having 2,2'-bipyridine and α-amino acid salicylaldininates as models for the type-2 sites in copper oxidases显示文摘REDDY P NETHAJI M CHAKRAVARTY A R 2002Inorganica Chimica Acta2002,337,:1
19Oral dydrogesterone versus intravaginal micronised progesterone as iuteal phase support in assisted reproductive technology (ART) cyclea results of a randomised study显示文摘Chakravarty BN Shirazee HH Dam P 2005J Steroid Biochem Mol Biol2005,97,5:1
20A new finite element model for welding heat sources显示文摘Goldak J A Chakravarti A P Bibby M 1984Metallurgical Transactions1984,,15:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费